Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States

Journal of Viral Hepatitis

Volumn 22, Issue 2, 2015, Pages 135-143

  Younossi, Z M ^a,b   Otgonsuren, M ^b   Henry, L ^b   Arsalla, Z ^b   Stepnaova, M ^a   Mishra, A ^a   Venkatesan, C ^a   Hunt, S ^b  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

Author keywords

Hepatitis C virus; National Inpatient Sample; outcomes

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEPATITIS C; HOME CARE; HOSPITAL CHARGE; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MORTALITY; PATIENT TRANSPORT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; ECONOMICS; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HEPATITIS C, CHRONIC; HOSPITAL; HOSPITAL PATIENT; INSURANCE; MALE; MIDDLE AGED; PATHOLOGY; STATISTICS AND NUMERICAL DATA; SURVIVAL; UTILIZATION;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HEPATITIS C, CHRONIC; HOSPITALS; HUMANS; INPATIENTS; INSURANCE COVERAGE; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84921354625     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12262     Document Type: Article

References (24)

1. Williams IT, Bell BP, Kuhnert W, et al,. Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006. Arch Intern Med 2011; 171 (3): 242-248.
2. Davis KL, Mitra D, Medjedovic J, et al,. Direct economic burden of chronic hepatitis C virus in a United States managed care population. J Clin Gastroenterol 2011; 45 (2): e17-e24.
3. Centers for Disease Control. Hepatitis C FAQ's for Health Care Professionals. Available at: http://www.cdc.gov/hepatitis/c/cFAQ.htm#overview (accessed 1 July 2013).
4. Grant WC, Jhaveri RR, McHutchison JG, et al,. Trends in health care resource use for hepatitis C virus infection in the United States. Hepatology 2005; 42 (6): 1406-1413.
5. Younossi Z, Zheng L, Stepanova M, et al,. Clinical Outcomes and Resource Utilization in Chronic Liver Disease-a Temporal Trends Study. BMJ In Press 2014.
6. Nationwide Inpatient Sample (NIS). Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp (accessed May 28, 2013).
7. Rodríguez-Mañero M, Bertomeu-González V, Cordero A, et al,. Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years. Rev Port Cardiol 2013; 32 (2): 103-109.
8. O'Brien C, Bray EP, Bryan S, et al,. Targets and self-management for the control of blood pressure in stroke and at risk groups (TASMIN-SR): protocol for a randomised controlled trial. BMC Cardiovasc Disord 2013; 13: 21.
9. Martin SC, Viljoen A,. The value of a specialist lipid clinic. Int J Clin Pract 2008; 62 (6): 961-966.
10. Centers for Disease Control- National Hospital Discharge Survey. Available at: http://www.cdc.gov/nchs/nhds.htm (accessed 1 July 2013).
11. HCUP Clinical Classifications Software (CCS) for ICD-9-CM. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp (accessed 1 July 2013).
12. American Health Information Management Association. "Evolution of DRGs (Updated)." Journal of AHIMA (Updated April 2010). Available at: http://library.ahima.org/xpedio/groups/public/documents/ahima/bok1-047260.hcsp?dDocName=bok1-047260 (accessed 13 April 2014).
13. Elixhauser A, Steiner C, Harris DR, et al,. Comorbidity measures for use with administrative data. Med Care 1998; 36 (1): 8-27.
14. Consumer Price Index (CPI)- Bureau of labor Statistics. Available at: http://www.bls.gov/cpi/ (accessed 1 July 2013).
15. Stepanova M, Kanwal F, El-Serag HB, Younossi ZM,. Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States. Hepatology 2011; 53 (3): 737-745.
16. Younossi Z, Stepanova M, Mishra A, et al,. The impact of chronic hepatitis C on resource utisation and in-patients mortality for Medicare beneficiaries between 2005 and 2010. Aliment Pharmacol Ther 2013; 38 (9): 1065-1075.
17. Menzin J, White LA, Nichols C, et al,. The economic burden of advanced liver disease among patients with hepatitis C virus: a large state Medicaid perspective. BMC Health Serv Res 2012; 12: 459.
18. Mitra D, Davis KL, Beam C, et al,. Treatment patterns and adherence among patients with chronic hepatitis C virus in a US managed care population. Value Health 2010; 13 (4): 479-486.
19. Tsui JI, Maselli J, Gonzales R,. Sociodemographic trends in national ambulatory care visits for hepatitis C virus infection. Dig Dis Sci 2009; 54 (12): 2694-2698.
20. LaPar DJ, Stukenborg GJ, Guyer RA, et al,. Primary payer status is associated with mortality and resource utilization for coronary artery bypass grafting. Circulation 2012; 126 (11 Suppl 1): S132-S139.
21. Allen LA, Smoyer Tomic KE, Wilson KL, Smith DM, Agodoa I,. The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type. J Med Econ 2013; 16 (1): 43-54.
22. Gordon SC, Pockros PJ, Terrault NA, et al,. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection. Hepatology 2012; 56 (5): 1651-1660.
23. Medicare Payment Advisory Commission. A Data Book: A health care spending and Medicare spending 2012. Available at: http://www.medpac.gov/documents/Jun12DataBookEntireReport.pdf (accessed on 14 Feb 2014).
24. US Department of Health and Human Services. Affordable Care Act. Available at: http://www.hhs.gov/opa/affordable-care-act/index.html (accessed on 14 Feb 2014).